What are the latest treatment options for new crowns

In China, the latest new coronavirus pneumonia is now treated with a combination of Chinese and Western medicine, based on the New Coronavirus Pneumonia Diagnostic and Treatment Program (Trial Ninth Edition), which provides isolation, general treatment, antiviral treatment, immunotherapy, anticoagulation, prone position treatment, psychological intervention, critical care supportive treatment, traditional Chinese medicine treatment and early rehabilitation. It is recommended to follow the doctor’s instructions for treatment. 1. Isolation: centralized isolation management for light cases, centralized treatment in designated hospitals for ordinary, heavy and critical cases, and early admission to ICU if necessary. 2. General treatment: bed rest, close monitoring of vital signs, oxygen therapy, antibacterial drug treatment. 3. Antiviral treatment: recommend applying ritonavir tablets, ambavizumab/romivizumab injection, COVID-19 human immunoglobulin, and recovery plasma of recovered patients for antiviral treatment. 4. Immunotherapy: glucocorticoids and interleukin 6 inhibitors can be used for immunotherapy. 5. Anticoagulation therapy: low molecular heparin anticoagulation. 6. Prone position treatment: It is recommended that heavy and critical patients should be in prone position for not less than 12 hours a day. 7. Psychological intervention: necessary psychological counseling. 8. Critical care support therapy: on the basis of the above treatment, actively prevent complications, treat underlying diseases, prevent secondary infections, and provide timely organ function support. 9. Traditional Chinese medicine treatment: Apply Chinese herbal soup, Chinese patent medicine and acupuncture for evidence-based treatment. 10. Early rehabilitation intervention: Early rehabilitation intervention should be carried out for the disease to maximize the recovery of physical ability, physique and immunity. Tips] The “new coronary pneumonia, new coronary virus pneumonia” mentioned in this article has been renamed to “new coronary virus infection” on December 26, 2022, as announced by the National Health Commission.